Major Medical Device Makers Including Medtronic, Johnson & Johnson, and Abbott Face Large-Scale Discontinuation of Products Amid National Price Governance Drive

On March 20, the Liaoning Provincial Drug and Medical Consumables Centralized Procurement Website released the "Notice on Launching the Price Regulation Work for the First Batch of Medical Consumables Listed for Procurement in Liaoning Province" (hereinafter referred to as the "Notice").

It is understood that the first batch of price governance consumables mainly targets 27 national medical insurance medical consumables.Same Code，Same Registration Certificate，The procurement price is the same as the listed price.，Same bidding company accountRepeated products.

The scope of the governance product involves the project includes:Non-volume and non-selected project products in volume-based procurement projects（Excluding products from bulk procurement projects and reagent products.）。

The Notice pointed out that, after the price governance, enterprisesAll types of consumables will retain only one numbering information., specific rules are as follows:

According to the above principles, the first round of price governance for medical consumables listed productsInvolving 58,515 products from 506 companies，After deduplication, 27,619 products were retained.Medtronic, Stryker, Abbott, Johnson & Johnson and other top medical device companies have a large number of products listed among them.

Among them, Johnson & Johnson has a total of 2,544 consumable products deduplicated, Medtronic 67, Stryker 128, Abbott 41, Dabo 2,658...

Click on the official account business card below and reply with "44”

View the "List of Price Governance for Medical Consumables Registered Products"

This timeThe information disclosure and appeal period will end on March 29, 2024.，Expires tomorrow。All companies must carefully verify the information related to the products and prices involved, so as not to hinder the normal online procurement process of the products.

As is known to all, before the consumable information of various provinces was connected to the national unified platform, due to the consumables...Complicated classification, inconsistent naming, and unclear classification criteriaAnd the various chaos caused by consumables occurs from time to time.

However, after provinces successively connected to the unified national medical insurance information system, the chaotic management of consumables was finally significantly improved.

Taking Anhui Province as an example, within half a year of启用新系统, more than 100,000耗材were拟被取消挂网due to coding mismatches. A rough estimate suggests that nearly...Millions of consumable products were disqualified from online listing due to "repeated code acquisition and fragmented code acquisition."

But distinguishing repetition, decomposing the code-taking, Liaoning Province's launch of "Four-Same Consumables" pricingGovernance, MainBy analyzing the information of medical consumables products listed onlineConduct sorting and deduplication, from the "extensive"Large-scaleCleaning, upgrading to more precise screening,Until the realization of each consumable productCorresponding to only one unique code and one clear price information.

"The Notice" also clearly states,This price governance action willStart in batches。This also means that,ThisThe field cleaning operation has just begun......

Previously, Shi Zihai, deputy director of the National Healthcare Security Administration, clearly pointed out during his research trip to Jiangsu and Zhejiang on the governance of listed drug prices:

According to incomplete statistics, currently in ChinaMore than twenty provinces in China have launched the "Medical Insurance Platform Procurement Management System."(Specific details can be found at the end of the text)。In 2023, multiple provinces in China, including Fujian, Jiangxi, Sichuan, Shaanxi, Hebei, and Guangdong, issued a series of documents:

During this period, there was also a large group ofDelayed price reduction, non-participation in centralized procurement, and untimely deliveryThe consumable products have been disqualified from the online listing.

Nowadays, with the issuance of this "Notice" by Liaoning, it will completelyStreamline the Complex and Complicated Information on the Medical Consumables Network, achieving deduplication and normalization.This not only provides greater convenience for the "whole-process" supervision of consumables but also will strongly promote the listing of consumables across China.Entering the Real "Price Naked Era", AchieveOne Object One Code Full Traceability, making prices simpler and more transparent, and information traceable.

Note:The above content is for reference only and does not constitute investment advice.The interpretation of official policies in this article only represents the views of this platform, and the content shall be subject to official documents. If any platform reprints this article, it shall be responsible for the article itself. The Medical Device Dealers Alliance and IVD Alliance are not responsible for the impact of secondary dissemination caused by the reprint.。